C57BL/6-Sting1em1Psou/Orl

Status

Available to order

EMMA IDEM:11025
Citation informationRRID:IMSR_EM:11025 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC57BL/6-Sting1em1Psou/Orl
Alternative nameSting V154M
Strain typeEndonuclease-mediated
Allele/Transgene symbolSting1em1Psou
Gene/Transgene symbolSting1

Information from provider

ProviderPauline Soulas-Sprauel
Provider affiliationCRBS (Centre de Recherche en Biomédecine), Inserm UMR 1109 (Immuno-Rhumatologie Moléculaire, IRM)
Additional ownerDr Frédéric Rieux-Laucat ; Imagine Institute ; Paris ; France
Genetic informationSting V154M mice carry a heterozygous mutation in the Sting1 gene. The mutation is the equivalent of the human p.V155M mutation, associated with STING-associated vasculopathy with onset in infancy (SAVI).
Phenotypic informationHomozygous:
Heterozygous females are sterile, therefore the phenotype of homozygous mice is not known.

Heterozygous:
Immunodeficiency characterized by a defect in B, T and NK lymphocyte development, and an increase in monocyte/granuloyte lineages. The size of thymus is reduced. Progressive weight loss.
Breeding historyOne founder was generated by CRISPR/Cas9, then backcrossed to C57BL/6 for 4 generations.
References
  • Severe combined immunodeficiency in stimulator of interferon genes (STING) V154M/wild-type mice.;Bouis Delphine, Kirstetter Peggy, Arbogast Florent, Lamon Delphine, Delgado Virginia, Jung Sophie, Ebel Claudine, Jacobs Hugues, Knapp Anne-Marie, Jeremiah Nadia, Belot Alexandre, Martin Thierry, Crow Yanick J, André-Schmutz Isabelle, Korganow Anne-Sophie, Rieux-Laucat Frédéric, Soulas-Sprauel Pauline, ;2019;The Journal of allergy and clinical immunology;143;712-725.e5; 29800647
Homozygous fertilenot known
Homozygous viablenot known
Homozygous matings requiredno
Immunocompromisedyes

Information from EMMA

Archiving centreCNRS-TAAM – Typing and Archiving of Animal Models, Orléans, France
Animals used for archivingheterozygous C57BL/6 males

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • female infertility / IMPC
  • enlarged heart / IMPC
  • abnormal heart morphology / IMPC
MGI phenotypes (gene matching)
  • abnormal humoral immune response / MGI
  • abnormal immune cell physiology / MGI
  • abnormal dendritic cell physiology / MGI
  • increased susceptibility to viral infection / MGI
  • abnormal innate immunity / MGI
  • abnormal macrophage physiology / MGI
  • no phenotypic analysis / MGI
  • abnormal response to infection / MGI
  • immune system phenotype / MGI
  • decreased circulating interferon-alpha level / MGI
  • decreased circulating interferon-beta level / MGI
  • decreased circulating interleukin-6 level / MGI
  • abnormal plasmacytoid dendritic cell physiology / MGI
  • increased susceptibility to viral infection induced morbidity/mortality / MGI

Literature references

  • Severe combined immunodeficiency in stimulator of interferon genes (STING) V154M/wild-type mice.;Bouis Delphine, Kirstetter Peggy, Arbogast Florent, Lamon Delphine, Delgado Virginia, Jung Sophie, Ebel Claudine, Jacobs Hugues, Knapp Anne-Marie, Jeremiah Nadia, Belot Alexandre, Martin Thierry, Crow Yanick J, André-Schmutz Isabelle, Korganow Anne-Sophie, Rieux-Laucat Frédéric, Soulas-Sprauel Pauline, ;2019;The Journal of allergy and clinical immunology;143;712-725.e5; 29800647

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable), as well as a CRISPR surcharge.

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).